Women with heart failure less likely to get heart pump device

By American Heart Association News

Tinpixels/E+, Getty Images
(Tinpixels/E+, Getty Images)

Women are less likely than men to receive a mechanical heart pump that is becoming the norm for people with advanced heart failure, according to new research.

The study, published Friday in the American Heart Association journal Circulation: Heart Failure, took a deeper look at long-standing differences in how women are treated for heart failure, a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body's needs for blood and oxygen. Heart failure affects 6.5 million Americans, a number projected to rise to 9 million by 2030.

About 10% of people with heart failure have an advanced form. Many receive a left ventricular assist device, or LVAD, a surgically implanted, battery-operated device that helps the heart circulate blood. For some people with advanced heart failure, an LVAD buys time before a heart transplant. Others get the device for longer-term therapy.

Research has shown certain groups are less likely to receive an LVAD.

People who live in low-income ZIP codes, are black or Hispanic or are uninsured or covered by Medicaid are less likely to get the devices, according to a study presented earlier this year at the AHA's Quality of Care and Outcomes Research Scientific Sessions. Past research also has shown women, who make up about one-third of advanced heart failure patients, receive less advanced therapy than men, including LVADs.

But for the new study, researchers wanted to see if LVAD gender disparity still occurs in the age of new-generation LVADs, which have gotten smaller, more durable and more popular.

Researchers looked at data from 29,934 hospitalizations from 2004 to 2016 in which people received LVADs. They found that while the devices were used more, women continued to represent a smaller proportion of LVAD recipients. In 2004, women made up 25.8% of the those who got LVADs, but that shrunk to 21.9% in 2016.

The study, which called LVADs a "potentially life-saving therapy," also showed a significant decrease in death rates in hospitals for both men and women who received the newer-generation devices.

Dr. Aditya Joshi, the study's lead author, said it is possible doctors are implanting fewer LVADs in women based on outdated statistics that showed women had higher death rates than men after receiving older-generation LVADs. He called for new and current epidemiologic studies to break down the occurrence of advanced heart failure by sex.

"Now that we're in an era with more durable and much smaller devices, the mortality difference between men and women has actually disappeared," he said. "We have to be more cognizant of the implicit bias that makes us choose different therapies for men and women."

Joshi, a cardiology fellow with the Mount Sinai Health System in New York, called for future in-depth research to confirm the findings.

Dr. Eileen Hsich, who was not involved in the study, said the research was limited by a lack of data on which patients were eligible for an LVAD and how many patients were offered them. She'd like future research also to focus on survival rates for LVAD patients versus heart transplant patients.

But she praised the work "for showing that with improvement in technology, there's also improvement in survival."

"We should all be excited about the results, which show that whether you're a man or a woman, these new devices are very effective at keeping people alive, and their complications rates are low," said Hsich, a cardiologist at the Kauffman Center for Heart Failure at the Cleveland Clinic.

Both men and women should learn more about LVADs and talk to their doctors about them as early as possible, she said.

"Education empowers patients. We need to open the conversation and prevent the fear factor so people can speak for themselves and advocate for better care."

If you have questions or comments about this story, please email [email protected]


American Heart Association News Stories

American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association. Statements, conclusions, accuracy and reliability of studies published in American Heart Association scientific journals or presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect the American Heart Association’s official guidance, policies or positions.

Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to American Heart Association News.

Other uses, including educational products or services sold for profit, must comply with the American Heart Association’s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.